Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Erik Hack

Showing results (11-20 of 165) with videos related to

Pageof 17
Sort By:
The Journal of Allergy and Clinical Immunology|April 25, 2006
Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiencyMarcel Levi, Goda Choi, Charles Picavet, et al.
The American Journal of Medicine|August 5, 2006
Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiencyMarcel Levi, C Erik Hack, Marinus H van Oers
Clinical Reviews in Allergy & Immunology|December 21, 2014
Hereditary Angioedema Attacks: Local Swelling at Multiple SitesZonne L M Hofman, Anurag Relan, C Erik Hack
Circulation|October 31, 2002
Safety of C1-inhibitor for clinical useC Erik Hack, Chris de Zwaan, Wim T Hermens
Blood|February 21, 2004
IVIg-mediated amelioration of murine ITP via FcgammaRIIb is not necessarily independent of SHIP-1 and SHP-1 activityEdwin van Mirre, Annet van Royen, C Erik Hack
Clinical Reviews in Allergy & Immunology|April 29, 2016
Bradykinin: Inflammatory Product of the Coagulation SystemZonne Hofman, Steven de Maat, C Erik Hack, et al.
Immunobiology|October 25, 2002
Structural and functional aspects of C1-inhibitorIneke G A Bos, C Erik Hack, Jan Pieter Abrahams
Journal of Clinical Pathology|September 28, 2010
Relation between coagulation/fibrinolysis and lactate in the course of human septic shockKoen J Hartemink, C Erik Hack, A B Johan Groeneveld
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 30, 2012
Immunogenicity assessment of recombinant human c1-inhibitor: an integrated analysis of clinical studiesC Erik Hack, Maurice Mannesse, Aartie Baboeram, et al.
Circulation|September 14, 2011
Letter by Krijnen et al regarding article, "The sPLA2 Inhibition to Decrease Enzyme Release after Percutaneous Coronary Intervention (SPIDER-PCI) trial"Paul A J Krijnen, C Erik Hack, Hans W M Niessen
Pageof 17

Showing results (11-20 of 165) with videos related to

Sort By:
Pageof 17
The Journal of Allergy and Clinical Immunology|April 25, 2006
Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiencyMarcel Levi, Goda Choi, Charles Picavet, et al.
The American Journal of Medicine|August 5, 2006
Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiencyMarcel Levi, C Erik Hack, Marinus H van Oers
Clinical Reviews in Allergy & Immunology|December 21, 2014
Hereditary Angioedema Attacks: Local Swelling at Multiple SitesZonne L M Hofman, Anurag Relan, C Erik Hack
Circulation|October 31, 2002
Safety of C1-inhibitor for clinical useC Erik Hack, Chris de Zwaan, Wim T Hermens
Blood|February 21, 2004
IVIg-mediated amelioration of murine ITP via FcgammaRIIb is not necessarily independent of SHIP-1 and SHP-1 activityEdwin van Mirre, Annet van Royen, C Erik Hack
Clinical Reviews in Allergy & Immunology|April 29, 2016
Bradykinin: Inflammatory Product of the Coagulation SystemZonne Hofman, Steven de Maat, C Erik Hack, et al.
Immunobiology|October 25, 2002
Structural and functional aspects of C1-inhibitorIneke G A Bos, C Erik Hack, Jan Pieter Abrahams
Journal of Clinical Pathology|September 28, 2010
Relation between coagulation/fibrinolysis and lactate in the course of human septic shockKoen J Hartemink, C Erik Hack, A B Johan Groeneveld
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 30, 2012
Immunogenicity assessment of recombinant human c1-inhibitor: an integrated analysis of clinical studiesC Erik Hack, Maurice Mannesse, Aartie Baboeram, et al.
Circulation|September 14, 2011
Letter by Krijnen et al regarding article, "The sPLA2 Inhibition to Decrease Enzyme Release after Percutaneous Coronary Intervention (SPIDER-PCI) trial"Paul A J Krijnen, C Erik Hack, Hans W M Niessen
Pageof 17